Category WTO/TRIPS

LDC Pharma Extension Request At WTO Yields Support But Needs Further Discussion

World Trade Organization members this week could not decide on a request from least-developed countries to extend a waiver allowing them to forego the enforcement of intellectual property rights on pharmaceutical products until their economies are stronger. Discussions are expected to be conducted informally until the next meeting of the organisation’s council on IP rights in October.

TRIPS Council To Discuss LDC Waiver Extension, Innovation This Week

The World Trade Organization committee on intellectual property and trade this week will discuss a range of issues including a request by least-developed countries to extend the time before they are required to enforce rules on IP and pharmaceuticals. Other issues include a discussion of IP and innovation, and a moratorium on complaints about government actions that do not violate WTO rules but may harm trade.

Alternative Summit Offers Ideas For Trade Agreements, G7, Amid 40,000 Protesters

MUNICH -- Just days before leaders of the Group of 7 (G7) industrialised countries gather in the well-guarded Bavarian Castle Elmau, a broad coalition of organisations invited free trade critics to an International Summit for Alternatives in Munich. Speaking there, Jean Ziegler, well-known former UN rapporteur for the right to food, shrugged off the possible effects of the G7 Summit.

European Parliament Trade Committee Tries To Defuse TTIP Controversy But Outcome Remains Uncertain

European Commission negotiators should back away from a controversial provision in the Transatlantic Trade and Investment Partnership (TTIP) deal that would allow companies to sue governments in arbitration courts over claimed unequal treatment, the European Parliament International Trade Committee (INTA) said on 28 May. MEPs called instead for publicly appointed, independent judges, public hearings and an appellate mechanism that respects the jurisdiction of EU and national courts, the committee said.

Industry Asks For Clarity On LDC Request To Extend TRIPS Pharma Waiver

Least developed countries (LDCs) at the World Trade Organization have requested that a waiver allowing them to not enforce intellectual property rights on pharmaceutical products be extended beyond its deadline of 1 January 2016. The brand pharmaceutical industry this week stated that it supports access to medicines for LDCs but does not see the need for this extension as LDCs already benefit from a WTO waiver on all products until 2021.

Seminar Discusses Global Value Chains And Development

Participation in global value chains contributes to economic growth, while trade and trade-related policies, such as foreign direct investment, intellectual property protection, trade facilitation, infrastructure and institutions, together with deeper regional integration have important impacts on global value chain integration in developing countries. This was the view of speakers at a recent event in Geneva.